Article PDF
References
Saxen, H., Nurminen, M., Kuusi, N., Svenson, S. B., Makela, P. H.: Evidence for the importance of O antigen specific antibodies in mouse-protective salmonella outer membrane protein (porin) antisera. Microbial Pathogenesis 1986, 1: 433–441.
van der Ley, P., Kuipers, O., Tommassen, J., Lugtenberg, B.: O-antigenic chains of lipopolysaccharide prevent binding of antibody molecules to an outer membrane pore protein inEnterobacteriaceae. Microbial Pathogenesis 1986, 1: 43–49.
van der Ley, P., de Graaff, P., Tommassen, J.: Shielding ofEscherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide. Journal of Bacteriology 1986, 168: 449–451.
Smit, J., Kamio, Y., Nikaido, H.: Outer membrane ofSalmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. Journal of Bacteriology 1975, 124: 942–958.
Gilleland, H. E., Stinnett, J. D., Roth, I. L., Eagon, R. G.: Freeze-etch study ofPseudomonas aeruginosa: localization within the cell wall of an ethylenediamine-tetraacetate-extractable component. Journal of Bacteriology 1973, 113: 417–432.
Roberts, N. A., Gray, G. W., Wilkinson, S. G.: The bactericidal action of ethylenediaminetetraacetic acid onPseudomonas aeruginosa. Microbios 1970, 2: 189–208.
van Alphen, L., Verkleij, A., Leunissen-Bijvelt, J., Lugtenberg, B.: Architecture of the outer membrane ofEscherichia coli III. Protein-lipopolysaccharide complexes in intramembraneous particles. Journal of Bacteriology 1978, 134: 1089–1098.
Hancock, R. E. W.: Intrinsic antibiotic resistance ofPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1986, 18: 653–656.
Nikaido, H.: Permeability of the outer membrane of bacteria. Angewandte Chemie 1979, 18: 337–350.
Mutharia, L. M., Hancock, R. E. W.: Surface localization ofPseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Infection and Immunity 1983, 42: 1027–1033.
Sokol, P. A., Woods, D. E.: Monoclonal antibodies toPseudomonas aeruginosa ferripyochelin-binding protein. Infection and Immunity 1986, 53: 621–627.
Hancock, R. E. W., Mutharia, L. M., Mouat, E. C. A.: Immunotherapeutic potential of monoclonal antibodies againstPseudomonas aeruginosa protein F. European Journal of Clinical Microbiology 1985, 4: 224–227.
Makela, P. H., Kuusi, N., Nurminen, M., Saxen, H., Valtonen, M.: Porins: the major outer membrane proteins of enteric bacteria as protective antigens. In: Robbins, J. B., Hill, J. C., Sadoff, J. C. (ed.): Seminars in infectious disease. Volume IV. Bacterial vaccines. Thieme-Stratton, New York, 1982, p. 360–365.
Frasch, C. E.: Status of a group BNeisseria meningitidis vaccine. European Journal of Clinical Microbiology 1985, 4: 533–536.
Sawada, S., Suzuki, M., Kawamura, T., Fujinaga, S., Masuho, Y., Tomibe, K.: Protection against infection withPseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins. Journal of Infectious Diseases 1984, 150: 570–576.
Siber, G. R., Kania, S. A., Warren, H. S.: Cross-reactivity of rabbit antibodies to lipopolysaccharides ofEscherichia coli J5 and other gram-negative bacteria. Journal of Infectious Diseases 1985, 152: 954–964.
Lambert, P. A., Booth, B. R.: Exposure of outer membrane proteins on the surface ofPseudomonas aeruginosa PAO1 revealed by labelling with [125I] lactoperoxidase. FEMS Microbiological Letters 1982, 14: 43–45.
Pennington, J. E., Small, G. J., Lostrom, M. E. Pier, G. B.: Polyclonal and monoclonal antibody therapy for experimentalPseudomonas aeruginosa pneumonia. Infection and Immunity 1986, 54: 239–244.
Gulig, P. A., McCracken, G. H., Frisch, C. F., Johnston, K. H., Hansen, E. J.: Antibody response of infants to cell surface-exposed outer membrane proteins ofHaemophilus influenzae type b after systemicHaemophilus disease. Infection and Immunity 1982, 37: 82–88.
Loeb, M. R., Smith, D. H.: Human antibody response to individual outer membrane proteins ofHaemophilus influenzae type b. Infection and Immunity 1982, 37: 1032–1036.
Brodeur, B. R., Larose, Y., Tsang, P., Hamel, J., Ashton, F., Ryan, A.: Protection against infection withNeisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infection and Immunity 1985, 50: 510–516.
Gilleland, H. E., Parker, M. G., Matthews, J. M., Berg, R. D.: Use of purified outer membrane protein F (porin) preparation ofPseudomonas aeruginosa as a protective vaccine in mice. Infection and Immunity 1984, 44: 49–54.
Matthews-Greer, J. M., Gilleland, H. E.: Outer membrane protein F (porin) preparation ofPseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. Journal of Infectious Diseases 1987, 155: 1282–1291.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilleland, H.E., Matthews-Greer, J.M. Perspectives on the potential for successful development of outer membrane protein vaccines. Eur. J. Clin. Microbiol. 6, 231–233 (1987). https://doi.org/10.1007/BF02017606
Issue Date:
DOI: https://doi.org/10.1007/BF02017606